219 related articles for article (PubMed ID: 17330963)
1. Bioinorganic chemistry of bismuth and antimony: target sites of metallodrugs.
Ge R; Sun H
Acc Chem Res; 2007 Apr; 40(4):267-74. PubMed ID: 17330963
[TBL] [Abstract][Full Text] [Related]
2. Reduction of pentavalent antimony by trypanothione and formation of a binary and ternary complex of antimony(III) and trypanothione.
Yan S; Li F; Ding K; Sun H
J Biol Inorg Chem; 2003 Jul; 8(6):689-97. PubMed ID: 12827457
[TBL] [Abstract][Full Text] [Related]
3. Indirect detection of protein-metal binding: interaction of serum transferrin with In3+ and Bi3+.
Zhang M; Gumerov DR; Kaltashov IA; Mason AB
J Am Soc Mass Spectrom; 2004 Nov; 15(11):1658-64. PubMed ID: 15519234
[TBL] [Abstract][Full Text] [Related]
4. The thiol-based reduction of Bi(V) and Sb(V) anti-leishmanial complexes.
Duffin RN; Stephens LJ; Blair VL; Kedzierski L; Andrews PC
J Inorg Biochem; 2021 Aug; 221():111470. PubMed ID: 33971522
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and characterization of bismuth(III) and antimony(III) calixarene complexes.
Liu L; Zakharov LN; Golen JA; Rheingold AL; Hanna TA
Inorg Chem; 2008 Dec; 47(23):11143-53. PubMed ID: 19228025
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and characterization of aspartic acid complexes of antimony and bismuth triiodide.
Jia RR; Wu CP; Wu S; Yang YX; Chen YR; Jia YQ
Amino Acids; 2006 Jul; 31(1):85-90. PubMed ID: 16583320
[TBL] [Abstract][Full Text] [Related]
7. Rapid reduction of pentavalent antimony by trypanothione: potential relevance to antimonial activation.
Yan S; Wong IL; Chow LM; Sun H
Chem Commun (Camb); 2003 Jan; (2):266-7. PubMed ID: 12585423
[TBL] [Abstract][Full Text] [Related]
8. Unexpectedly strong binding of a large metal ion (Bi3+) to human serum transferrin.
Li H; Sadler PJ; Sun H
J Biol Chem; 1996 Apr; 271(16):9483-9. PubMed ID: 8621619
[TBL] [Abstract][Full Text] [Related]
9. Conformational analyses and docking studies of a series of 5-nitrofuran- and 5-nitrothiophen-semicarbazone derivatives in three possible binding sites of trypanothione and glutathione reductases.
Vega-Teijido M; Caracelli I; Zukerman-Schpector J
J Mol Graph Model; 2006 Mar; 24(5):349-55. PubMed ID: 16275032
[TBL] [Abstract][Full Text] [Related]
10. Identification of bismuth-thiolate-carboxylate clusters by electrospray ionization mass spectrometry.
Phillips HA; Burford N
Inorg Chem; 2008 Apr; 47(7):2428-41. PubMed ID: 18293918
[TBL] [Abstract][Full Text] [Related]
11. Thermodynamic and kinetic aspects of metal binding to the histidine-rich protein, Hpn.
Ge R; Zhang Y; Sun X; Watt RM; He QY; Huang JD; Wilcox DE; Sun H
J Am Chem Soc; 2006 Sep; 128(35):11330-1. PubMed ID: 16939237
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in bioinorganic chemistry of bismuth.
Li H; Sun H
Curr Opin Chem Biol; 2012 Apr; 16(1-2):74-83. PubMed ID: 22322154
[TBL] [Abstract][Full Text] [Related]
13. Antimony resistance and trypanothione in experimentally selected and clinical strains of Leishmania panamensis.
Goyeneche-Patino DA; Valderrama L; Walker J; Saravia NG
Antimicrob Agents Chemother; 2008 Dec; 52(12):4503-6. PubMed ID: 18824610
[TBL] [Abstract][Full Text] [Related]
14. N-lobe versus C-lobe complexation of bismuth by human transferrin.
Sun H; Li H; Mason AB; Woodworth RC; Sadler PJ
Biochem J; 1999 Jan; 337 ( Pt 1)(Pt 1):105-11. PubMed ID: 9854031
[TBL] [Abstract][Full Text] [Related]
15. Chemistry and Some Biological Potential of Bismuth and Antimony Dithiocarbamate Complexes.
Adeyemi JO; Onwudiwe DC
Molecules; 2020 Jan; 25(2):. PubMed ID: 31940910
[TBL] [Abstract][Full Text] [Related]
16. Determination of drug binding sites to proteins by electrospray ionisation mass spectrometry: the interaction of cisplatin with transferrin.
Allardyce CS; Dyson PJ; Coffey J; Johnson N
Rapid Commun Mass Spectrom; 2002; 16(10):933-5. PubMed ID: 11968124
[TBL] [Abstract][Full Text] [Related]
17. Definitive identification of cysteine and glutathione complexes of bismuth by mass spectrometry: assessing the biochemical fate of bismuth pharmaceutical agents.
Burford N; Eelman MD; Mahony DE; Morash M
Chem Commun (Camb); 2003 Jan; (1):146-7. PubMed ID: 12611008
[TBL] [Abstract][Full Text] [Related]
18. The cytotoxicity of organobismuth compounds with certain molecular structures can be diminished by replacing the bismuth atom with an antimony atom in the molecules.
Kohri K; Yoshida E; Yasuike S; Fujie T; Yamamoto C; Kaji T
J Toxicol Sci; 2015 Jun; 40(3):321-7. PubMed ID: 25972193
[TBL] [Abstract][Full Text] [Related]
19. Reactions of PtII diamine anticancer complexes with trypanothione and octreotide.
Munk VP; Fakih S; Socorro Murdoch PD; Sadler PJ
J Inorg Biochem; 2006 Dec; 100(12):1946-54. PubMed ID: 17046064
[TBL] [Abstract][Full Text] [Related]
20. New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate.
Frézard F; Martins PS; Barbosa MC; Pimenta AM; Ferreira WA; de Melo JE; Mangrum JB; Demicheli C
J Inorg Biochem; 2008 Apr; 102(4):656-65. PubMed ID: 18061680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
